Table 2

Occurrence of contrast nephropathy (several definitions) according to the group of inclusion (placebo or n-acetylcysteine)
Event Placebo NAC P-value
(n = 58) (n = 52)
25% increase of creatinine or cystatin C 13 (22.4%) 14 (26.9%) 0.66
25% increase creatinine 10 (17.2%) 8 (15.4%) 0.99
25% increase cystatin C 9 (15.5%) 9 (17.3%) 0.99
AKIN stage 1 11 (19.0%) 13 (25.0%) 0.49
AKIN all stages 12 (20.7%) 13 (25.0%) 0.65

Poletti et al.

Poletti et al. BMC Nephrology 2013 14:119   doi:10.1186/1471-2369-14-119

Open Data